Markets
markets
Luke Kawa

Lumentum soars 50% in November as Wall Street and retail traders gush over the Google supplier

The Google halo effect is the new Nvidia halo effect.

Shares of optical and photonics company Lumentum have been on a tear in November, up nearly 50%. Its components help information move around quickly in data centers using lasers and mirrors.

Unlike a lot of the more speculative, volatile AI-adjacent stocks that have come under pressure as of late, Lumentum has strong operating performance to help justify these gains.

The company reported Q1 2026 results near the start of the month that exceeded analysts’ expectations, with management also offering Q2 guidance well ahead of forecasts.

The company’s fiscal 2025 results (the year ended June 28, 2025) showed that Google was its second-biggest customer, accounting for 15.4% of net revenues. Networking equipment company Ciena Corp. came in slightly higher, at 16%.

Bloomberg currently estimates that as of its most recent quarter, 22% and 21% of Lumentum’s sales come from Ciena and Google, respectively.

Retail traders have stampeded into the stock this month, per JPMorgan analyst Arun Jain.

JPM Retail Lumentum

Wall Street has been singing the company’s praises as of late, too. Needham analyst Ryan Koontz boosted his price target to $290 from $235 on Monday, while Rosenblatt’s Mike Genovese recently called it “a must own AI stock.”

More Markets

See all Markets
markets

Hims jumps after RFK Jr. announces FDA may loosen regulations for 12 peptides

Hims & Hers rose more than 13% on Wednesday and continued to rise in premarket trading on Thursday after Health Secretary Robert F. Kennedy Jr. said that the Food and Drug Administration could ease restrictions on 12 peptides.

The move would allow compounding pharmacies to dispense the list of peptides, which have grown in popularity but are currently only available through suppliers who sell them for research purposes.

Hims and other consumer health companies have positioned themselves to begin selling peptides after getting the FDA nod.

Hims and other consumer health companies have positioned themselves to begin selling peptides after getting the FDA nod.

markets

Oracle, Microsoft power battered software stocks toward best 3-day stretch in almost a year

Software shares are rising again early Wednesday, putting the widely watched iShares Expanded Tech Software ETF on track for its best three-day stretch in almost a year.

So far this week, Oracle is up more than 20%, Microsoft is up over 9%, and both ServiceNow and Datadog have gained more than 12%.

Intuit, CrowdStrike, Autodesk, and Atlassian were also among the software shares rising Wednesday after taking lumps on worries about AI disruption earlier this year.

Why the rebound? Mean reversion is a powerful force in markets, and some of these shares could simply be enjoying an overdue snapback.

Bloomberg suggests there’s some “bottom fishing” going on, with investors finally deciding that the price for these still highly profitable, cash flow-positive companies has fallen low enough to make them a compelling bargain.

Pat Tschosik, chief thematic strategist at research firm Ned Davis, told Sherwood News that the market may have been too panicky about software stocks as a whole, slamming the shares of software companies that could survive and thrive in the AI era along with those doomed to disruption.

Determining the difference between the winners and the losers will take a look at the fundamentals of individual companies.

“Somebody who does the homework is going to make a lot of money in these stocks,” he said.

So far this week, Oracle is up more than 20%, Microsoft is up over 9%, and both ServiceNow and Datadog have gained more than 12%.

Intuit, CrowdStrike, Autodesk, and Atlassian were also among the software shares rising Wednesday after taking lumps on worries about AI disruption earlier this year.

Why the rebound? Mean reversion is a powerful force in markets, and some of these shares could simply be enjoying an overdue snapback.

Bloomberg suggests there’s some “bottom fishing” going on, with investors finally deciding that the price for these still highly profitable, cash flow-positive companies has fallen low enough to make them a compelling bargain.

Pat Tschosik, chief thematic strategist at research firm Ned Davis, told Sherwood News that the market may have been too panicky about software stocks as a whole, slamming the shares of software companies that could survive and thrive in the AI era along with those doomed to disruption.

Determining the difference between the winners and the losers will take a look at the fundamentals of individual companies.

“Somebody who does the homework is going to make a lot of money in these stocks,” he said.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.